Cardiovascular Multimodality Imaging Study

Summary

Determining the etiology of cardiomyopathy is of high clinical importance for optimal treatment strategy and prediction of prognosis. There is increased risk for cardiovascular disease and higher propensity for cardiovascular related mortality among Black and non-Hispanic White patients. Recently, advanced cardiac imaging has become a vital tool in diagnosis and risk stratification of cardiovascular disease.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

• Non-ischemic Cardiomyopathy
• Cardiomyopathies
• Hypertrophic Cardiomyopathy
• Right Ventricular Arrhythmogenic Cardiomyopathy
• Cardiac Amyloidosis
• Anderson Fabry Disease
• Sarcoidosis
• Cancer Therapy-related Cardiac Dysfunction
• Ventricular Arrythmia
• Heart Failure

Eligibility basics and study details

Study type

Observational

Phase

Not applicable

Ages

18 years and older

Sex

All

Healthy volunteers

Not accepted

Sponsor

Montefiore Medical Center

Last updated on ClinicalTrials.gov

August 10, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites